Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Downgrade
Exelixis just downgraded at Barclays, here's why » 04:42
04/11/24
04/11
04:42
04/11/24
04:42
EXEL

Exelixis

$23.68 /

-0.06 (-0.25%)

Barclays downgraded…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:13
03/11/24
03/11
11:13
03/11/24
11:13
TCON

Tracon Pharmaceuticals

/

+

, EXEL

Exelixis

$22.35 /

+0.15 (+0.68%)

These names in the…

Open Full Text

Hot Stocks
Exelixis exec Haley sells 47,020 common shares » 19:01
02/27/24
02/27
19:01
02/27/24
19:01
EXEL

Exelixis

$21.73 /

-0.24 (-1.09%)

In a regulatory filing,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Fly Insider: Exelixis, Akami among week's notable insider trades » 15:11
02/26/24
02/26
15:11
02/26/24
15:11
ADC

Agree Realty

$56.77 /

-0.74 (-1.29%)

, EXEL

Exelixis

$21.82 /

+0.28 (+1.30%)

, HRTG

Heritage Insurance

$7.09 /

-0.03 (-0.42%)

, HLF

Herbalife

$8.71 /

+0.035 (+0.40%)

, ABNB

Airbnb

$149.01 /

-3.64 (-2.38%)

, AKAM

Akamai

$109.25 /

+1.08 (+1.00%)

, AGYS

Agilysys

$80.14 /

-0.22 (-0.27%)

, AL

Air Lease

$39.78 /

-0.2 (-0.50%)

Welcome to "Fly Insider,"…

Open Full Text

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:12
02/09/24
02/09
11:12
02/09/24
11:12
ADXS

Ayala Pharmaceuticals

$1.07 /

-0.07 (-6.14%)

, TENX

Tenax Therapeutics

$4.85 /

-0.2 (-3.96%)

, NVIV

InVivo Therapeutics

/

+

, EQ

Equillium

$1.69 /

+0.17 (+11.18%)

, MDGL

Madrigal Pharmaceuticals

$175.81 /

+4.1 (+2.39%)

, AKRO

Akero Therapeutics

$19.06 /

+0.52 (+2.80%)

, XCUR

Exicure

/

+

, RGNX

Regenxbio

$17.96 /

+1.66 (+10.18%)

, EXEL

Exelixis

$20.11 /

-0.07 (-0.35%)

, ETNB

89bio

$8.37 /

-0.08 (-0.95%)

, IMNM

Immunome

$23.39 /

-0.1 (-0.43%)

These names in the…

Open Full Text

Earnings
Exelixis backs FY24 revenue view $1.825B-$1.925B, consensus $1.91B 16:18
02/06/24
02/06
16:18
02/06/24
16:18
EXEL

Exelixis

$21.85 /

+0.43 (+2.01%)

 
Earnings
Exelixis reports Q4 adjusted EPS 33c, consensus 21c » 16:17
02/06/24
02/06
16:17
02/06/24
16:17
EXEL

Exelixis

$21.85 /

+0.43 (+2.01%)

Reports Q4 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cybrexa regains rights to CBX-12 » 08:12
02/06/24
02/06
08:12
02/06/24
08:12
EXEL

Exelixis

$21.42 /

-0.06 (-0.28%)

Cybrexa Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Exelixis price target raised by $1 at Barclays, here's why » 05:26
01/30/24
01/30
05:26
01/30/24
05:26
EXEL

Exelixis

$21.90 /

-0.21 (-0.95%)

Barclays raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 11:50
01/29/24
01/29
11:50
01/29/24
11:50
EXEL

Exelixis

$21.94 /

-0.17 (-0.77%)

, MRK

Merck

$120.81 /

+ (+0.00%)

, ESSA

ESSA Bancorp

$20.39 /

+ (+0.00%)

, AKAM

Akamai

$123.14 /

+0.09 (+0.07%)

, JNJ

Johnson & Johnson

$159.70 /

+0.2 (+0.13%)

, PFE

Pfizer

$27.39 /

-0.085 (-0.31%)

, ORIC

Oric Pharmaceuticals

$11.14 /

+0.925 (+9.06%)

, MGNX

MacroGenics

$13.35 /

+0.135 (+1.02%)

, LLY

Eli Lilly

$643.87 /

+4.63 (+0.72%)

, AMGN

Amgen

$312.36 /

+0.37 (+0.12%)

, ARVN

Arvinas

$39.10 /

+2.28 (+6.19%)

, FUSN

Fusion Pharmaceuticals

$11.05 /

+0.2 (+1.84%)

Biotech Analysts Agrawal,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 04:55
01/29/24
01/29
04:55
01/29/24
04:55
EXEL

Exelixis

$22.11 /

+0.015 (+0.07%)

, MRK

Merck

$120.81 /

+0.63 (+0.52%)

, ESSA

ESSA Bancorp

$20.39 /

+0.1 (+0.49%)

, AKAM

Akamai

$123.05 /

-0.64 (-0.52%)

, JNJ

Johnson & Johnson

$159.50 /

-0.1 (-0.06%)

, PFE

Pfizer

$27.47 /

+ (+0.00%)

, ORIC

Oric Pharmaceuticals

$10.22 /

-0.195 (-1.87%)

, MGNX

MacroGenics

$13.21 /

+0.44 (+3.45%)

, LLY

Eli Lilly

$639.24 /

+11.61 (+1.85%)

, AMGN

Amgen

$311.99 /

+1.78 (+0.57%)

, ARVN

Arvinas

$36.82 /

-0.92 (-2.44%)

, FUSN

Fusion Pharmaceuticals

$10.85 /

+0.2 (+1.88%)

Biotech Analysts Agrawal,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Exelixis announces results of study evaluating cabozantinib in mCRPC treatment » 08:10
01/25/24
01/25
08:10
01/25/24
08:10
EXEL

Exelixis

$22.12 /

-0.49 (-2.17%)

Exelixis announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 16:47
01/24/24
01/24
16:47
01/24/24
16:47
EXEL

Exelixis

$22.12 /

-0.49 (-2.17%)

, MRK

Merck

$118.89 /

-0.96 (-0.80%)

, ESSA

ESSA Bancorp

$19.87 /

+0.02 (+0.10%)

, AKAM

Akamai

$123.73 /

+0.47 (+0.38%)

, JNJ

Johnson & Johnson

$158.96 /

-0.815 (-0.51%)

, PFE

Pfizer

$28.34 /

-0.09 (-0.32%)

, ORIC

Oric Pharmaceuticals

$10.89 /

+0.075 (+0.69%)

, MGNX

MacroGenics

$12.01 /

+0.01 (+0.08%)

, LLY

Eli Lilly

$633.85 /

+4.325 (+0.69%)

, AMGN

Amgen

$305.36 /

-4.53 (-1.46%)

, ARVN

Arvinas

$36.75 /

+0.39 (+1.07%)

, FUSN

Fusion Pharmaceuticals

$10.04 /

+0.365 (+3.77%)

Biotech Analysts Agrawal,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Bristol Myers, Exelixis announce four-year results from Opdivo-Cabometyx trial » 17:03
01/22/24
01/22
17:03
01/22/24
17:03
BMY

Bristol Myers

$49.57 /

-0.54 (-1.08%)

, EXEL

Exelixis

$22.66 /

+0.18 (+0.80%)

Bristol Myers (BMY) and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
EPO rules in favor of Exelixis on patent covering Cabometyx » 16:08
01/18/24
01/18
16:08
01/18/24
16:08
EXEL

Exelixis

$22.28 /

-0.255 (-1.13%)

, TEVA

Teva

$10.99 /

-0.05 (-0.45%)

Exelixis announced it has…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:12
01/10/24
01/10
11:12
01/10/24
11:12
HARP

Harpoon Therapeutics

$22.46 /

+0.12 (+0.54%)

, CLRB

Cellectar Biosciences

$3.52 /

-0.125 (-3.43%)

, CYCC

Cyclacel Pharmaceuticals

$3.12 /

-0.235 (-7.00%)

, ARDX

Ardelyx

$8.99 /

-0.105 (-1.15%)

, INVA

Innoviva

$16.48 /

+0.035 (+0.21%)

, HRTX

Heron Therapeutics

$2.25 /

-0.005 (-0.22%)

, BCRX

BioCryst

$7.15 /

-0.295 (-3.96%)

, MESO

Mesoblast

$1.94 /

-0.13 (-6.28%)

, AMPE

Ampio

$2.48 /

+0.26 (+11.71%)

, EXEL

Exelixis

$22.95 /

-0.3 (-1.29%)

, MRK

Merck

$118.32 /

-0.08 (-0.07%)

These names in the…

Open Full Text

Earnings
Exelixis reports preliminary FY23 revenue $1.83B, consensus 1.84B » 17:00
01/07/24
01/07
17:00
01/07/24
17:00
EXEL

Exelixis

$23.22 /

-0.37 (-1.57%)

Sees FY24 revenue of…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Exelixis initiated with bullish view at BTIG, here's why » 07:14
12/19/23
12/19
07:14
12/19/23
07:14
EXEL

Exelixis

$23.34 /

-0.07 (-0.30%)

BTIG initiated coverage…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Exelixis initiated with bullish view at Citi, here's why » 05:47
12/15/23
12/15
05:47
12/15/23
05:47
EXEL

Exelixis

$23.30 /

-0.305 (-1.29%)

Citi initiated coverage…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Exelixis, Arcus team on trial of zanzalintinib-AB521 combo to treat ccRCC » 08:28
12/04/23
12/04
08:28
12/04/23
08:28
EXEL

Exelixis

$21.95 /

+0.115 (+0.53%)

, RCUS

Arcus Biosciences

$16.06 /

+1.03 (+6.85%)

Exelixis( EXEL) and Arcus…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Exelixis initiates STELLAR-305 trial evaluating zanzalintinib combo for SCCHN » 08:09
12/04/23
12/04
08:09
12/04/23
08:09
EXEL

Exelixis

$21.95 /

+0.115 (+0.53%)

Exelixis announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Exelixis announces initial results from expansion cohort of STELLAR-001 study » 09:11
11/10/23
11/10
09:11
11/10/23
09:11
EXEL

Exelixis

$21.03 /

+0.28 (+1.35%)

Exelixis announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Exelixis narrows FY23 revenue view to $1.825B-$1.85B from $1.775B-$1.875B 16:56
11/01/23
11/01
16:56
11/01/23
16:56
EXEL

Exelixis

$21.04 /

+0.445 (+2.16%)

Consensus $1.84B.
Earnings
Exelixis reports Q3 adjusted EPS 10c, consensus 15c » 16:56
11/01/23
11/01
16:56
11/01/23
16:56
EXEL

Exelixis

$21.04 /

+0.445 (+2.16%)

Reports Q3 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:01
10/26/23
10/26
11:01
10/26/23
11:01
CTXR

Citius Pharmaceuticals

/

+

, HARP

Harpoon Therapeutics

$4.79 /

-0.2 (-4.01%)

, IMGN

ImmunoGen

$14.33 /

+0.635 (+4.64%)

, EVFM

Evofem

/

+

, SGEN

Seagen

$216.14 /

-0.53 (-0.24%)

, EXEL

Exelixis

$20.39 /

+0.51 (+2.57%)

, GMAB

Genmab

$28.57 /

-0.48 (-1.65%)

These names in the…

Open Full Text

Recommendations
Exelixis price target raised to $27 from $25 at BofA » 09:15
10/12/23
10/12
09:15
10/12/23
09:15
EXEL

Exelixis

$21.50 /

-0.115 (-0.53%)

BofA raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Options
Exelixis call buyer realizes 35% same-day gains » 08:00
09/28/23
09/28
08:00
09/28/23
08:00
EXEL

Exelixis

$22.18 /

+0.425 (+1.95%)

Notable profits for the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Exelixis initiated with a Buy at H.C. Wainwright » 06:07
09/26/23
09/26
06:07
09/26/23
06:07
EXEL

Exelixis

$21.83 /

+0.335 (+1.56%)

H.C. Wainwright initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Exelixis price target raised to $30 from $27 at Guggenheim » 06:51
09/25/23
09/25
06:51
09/25/23
06:51
EXEL

Exelixis

$21.49 /

-0.075 (-0.35%)

Guggenheim raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Exelixis in $80M deal with Insilico for global rights to develop ISM3091 » 08:16
09/12/23
09/12
08:16
09/12/23
08:16
EXEL

Exelixis

$21.98 /

-0.13 (-0.59%)

Exelixis (EXEL) and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.